Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2006-06-12 Director's Dealing
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2006-06-12 English
FORM S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC under the Securities Act of 1933. It relates to the registration of securities under an employee stock option plan. The text includes details about the registration fee, plan information, incorporation by reference of prior filings (including an Annual Report on Form 10-KSB), indemnification provisions, and signatures of company officers. Form S-8 is a registration statement for securities to be offered to employees and is a type of capital raising or financing filing. It is not an annual report, earnings release, or other financial report. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2006-05-12 English
10QSBMARCH312006
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is explicitly described as a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended March 31, 2006. It contains detailed consolidated financial statements including balance sheets, statements of operations, shareholders' equity, cash flows, and notes to financial statements. It also includes management's discussion and analysis, legal proceedings, and other information typical of an interim quarterly report. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2006-05-10 English
FORM 10KSB
Annual Report Classification · 100% confidence The document is titled 'FORM 10KSB' and explicitly states it is an 'ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended December 31, 2005. It includes detailed sections typical of an annual report such as Description of Business, Legal Proceedings, Management's Discussion and Analysis, Financial Statements, and Executive Compensation. The length of the document (15,000 characters) and the presence of substantive business and financial information confirm it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K).
2006-03-29 English
PRIMARY DOCUMENT
Director's Dealing
2006-02-28 English
PRIMARY DOCUMENT
Director's Dealing
2006-02-28 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.